Načítá se...

Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study

AIMS/HYPOTHESIS: Liraglutide can modulate insulin secretion by directly stimulating beta cells or indirectly through weight loss and enhanced insulin sensitivity. Recently, we showed that liraglutide treatment in overweight individuals with prediabetes (impaired fasting glucose and/or impaired gluco...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetologia
Hlavní autoři: Kim, Sun H., Liu, Alice, Ariel, Danit, Abbasi, Fahim, Lamendola, Cindy, Grove, Kaylene, Tomasso, Vanessa, Reaven, Gerald
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072364/
https://ncbi.nlm.nih.gov/pubmed/24326527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-013-3134-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!